About the Company
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $VRTX News
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
For those with $1,000 to spare, let's consider two healthcare stocks worth investing in and holding onto for a long time: ...
New Non-Opioid Pain Meds Hold Promise, But Face Clinical Development And Insurer Challenges
There’s no denying that prescription opioids can be misused, abused, and diverted. And so, given these risks, there’s a ...
Vertex Pharmaceuticals Inc VRTX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Forget Tesla, Buy This Magnificent Healthcare Stock Instead
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
A New Cause for Concern: Vertex Pharmaceuticals Inc. Adds a New Regulation Risk
Vertex Pharmaceuticals Inc. (VRTX) has disclosed a new risk, in the Regulation category. Vertex Pharmaceuticals Inc. confronts a significant hurdle as the public and medical communities ...
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with ...
Vertex’s Alternative to Opioids Meets Goal in Pivotal Trial
(Bloomberg) -- Vertex Pharmaceuticals Inc.’s nonaddictive drug helped patients with acute pain after surgery in a pivotal study but the results didn’t show superiority to opioids, raising ...
Vertex grew headcount 13% in 2023, plans for more hiring in 2024
Even as dozens of local biotech companies reduced headcount last year, Vertex Pharmaceuticals Inc. was among those that grew its total workforce. Vertex (Nasdaq: VRTX) increased its total employee ...
Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) maintains a robust market position with a focus on cystic fibrosis treatments and a growing presence in gene-editing therapies. Despite strong competition ...
Vertex Pharmaceuticals files patent for cell housing device with array of chemicals to increase surface area
Discover how Vertex Pharmaceuticals Inc. innovates with a patent for a cell housing device, using sintering and fusing membranes to create compartments for cell populations. Explore the detailed ...
Loading the latest forecasts...